Largest of Its Kind Study Examines Safety of Systemic Treatments for Patients With Psoriasis
A large new study has evaluated the risk of infection associated with various biologic therapies for patients with psoriasis finding that th
top of page
it's where dermatology lives
by Bianca Quijano
Mar 5, 20182 min read
Ustekinumab also reduces aortic vascular inflammation
“This study represents promise that this treatment may reduce the risk of heart attack and stroke in the future. It’s an encouraging finding
By John Evans, Associate Editor
Dec 5, 20162 min read
Psoriasis drug may be hitting too many targets
Targeting interleukin (IL)-12 as part of psoriasis treatment may be counterproductive, according to findings from a recent study...
Featured Posts
bottom of page